Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gradient boosting-based discrete failure time model for selecting time-varying effects and interactions.

Lifetime data analysis·2026
Same author

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

α/β for Hepatocellular Carcinoma Tumors Treated With Radiation Therapy.

International journal of radiation oncology, biology, physics·2026
Same author

KULLBACK-LEIBLER-BASED DISCRETE FAILURE TIME MODELS FOR INTEGRATION OF PUBLISHED PREDICTION MODELS WITH NEW TIME-TO-EVENT DATASET.

The annals of applied statistics·2026
Same author

Impact of neighbor-level disadvantage on survival outcomes in head and neck squamous cell carcinoma.

Cancer causes & control : CCC·2025
Same author

A Multiple Imputation Approach for the Cumulative Incidence, with Implications for Variance Estimation.

The American statistician·2025
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Subgroup identification from randomized clinical trial data.

Jared C Foster1, Jeremy M G Taylor, Stephen J Ruberg

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.

Statistics in Medicine
|August 5, 2011
PubMed
Summary
This summary is machine-generated.

Identifying patient subgroups with enhanced treatment effects in clinical trials is crucial. The Virtual Twins method predicts individual treatment responses, outperforming traditional methods for subgroup analysis.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 30, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Translational Medicine

Background:

  • Subgroup analysis in randomized clinical trials (RCTs) aims to identify patient groups with differential treatment effects.
  • Standard subgroup analyses are prone to false discoveries and lack pre-specified strategies.
  • Identifying subgroups with enhanced treatment effects requires robust methodologies to avoid biases.

Purpose of the Study:

  • To introduce and evaluate the 'Virtual Twins' method for identifying patient subgroups with enhanced treatment effects in RCTs.
  • To provide a standard, pre-determined strategy for subgroup identification, mitigating risks associated with traditional subgroup analyses.
  • To develop and assess methods for estimating the magnitude of treatment effect enhancement within identified subgroups.

Main Methods:

  • The Virtual Twins method predicts individual response probabilities for both treatment and control arms.
  • The difference in predicted probabilities serves as the outcome for classification or regression trees, incorporating various covariates.
  • Multiple estimation strategies for quantifying subgroup treatment effect enhancement (Q(Â)) are proposed, including simulation, cross-validation, and bootstrap approaches.

Main Results:

  • Simulation studies demonstrate that the Virtual Twins method significantly outperforms logistic regression with forward selection in detecting true subgroups with enhanced treatment effects.
  • The effectiveness of subgroup estimation is generally dependent on large sample sizes or substantial treatment effect enhancements.
  • The proposed methods were successfully applied to real-world data from a randomized clinical trial.

Conclusions:

  • The Virtual Twins method offers a promising, data-driven approach for identifying patient subgroups with superior treatment responses in clinical trials.
  • Careful consideration of sample size and effect size is necessary for reliable subgroup estimation.
  • This methodology provides a valuable tool for personalized medicine and optimizing treatment strategies.